Revvity Inc.
RVTY
$152.17-1.88%
End of day · as of Oct 15, 2026, 2:00 AM ET
Mkt cap
$11.94B
EV/Sales
4.99
P/E ratio
73.2
FY2025 Revenue
$2.86B
EPS (TTM)
$2.08
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
8.45%
Beta
0.97
Div yield
0.29%
Sector
Healthcare
No recent filings in cache.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported RVTY revenue for 2025-12-28 was $2.86B. Net income was $241.2M. Revenue was up 3.7% from 2024-12-29 to 2025-12-28. RVTY currently screens at market cap $11.94B and trailing P/E 73.2.
Use this RVTY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RVTY income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Revvity Inc. (RVTY) is a diagnostics & research company in the Healthcare sector.
Latest cached Revvity Inc. (RVTY) revenue for Dec 28, 2025 was $2.86B. Net income was $241.2M. Statements: https://lician.com/financials/rvty
Revvity Inc. (RVTY) trailing P/E is 73.2 on the latest cached fundamentals snapshot.
Revvity Inc. (RVTY) market capitalization is $11.94B on the latest cached snapshot.
Revvity Inc. (RVTY) cached previous close $155.08; day range $152.12 – $154.26; volume 2,014,266. Session quote: https://lician.com/quote/rvty